These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 18271715)

  • 21. Challenges in the search for drugs to treat central nervous system disorders.
    Enna SJ; Williams M
    J Pharmacol Exp Ther; 2009 May; 329(2):404-11. PubMed ID: 19182069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycine transporter isoforms in the mammalian central nervous system: structures, functions and therapeutic promises.
    Gomeza J; Ohno K; Betz H
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):675-82. PubMed ID: 14579517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cell-based cell therapy in neurological diseases: a review.
    Kim SU; de Vellis J
    J Neurosci Res; 2009 Aug; 87(10):2183-200. PubMed ID: 19301431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurogenesis in adult CNS: from denial to opportunities and challenges for therapy.
    Colucci-D'Amato L; di Porzio U
    Bioessays; 2008 Feb; 30(2):135-45. PubMed ID: 18200551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relevance of symmetric and asymmetric cell divisions to human central nervous system diseases.
    Yong KJ; Yan B
    J Clin Neurosci; 2011 Apr; 18(4):458-63. PubMed ID: 21288724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult neurogenesis in the mammalian central nervous system.
    Ming GL; Song H
    Annu Rev Neurosci; 2005; 28():223-50. PubMed ID: 16022595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human stem cells for modeling neurological disorders: accelerating the drug discovery pipeline.
    Crook JM; Kobayashi NR
    J Cell Biochem; 2008 Dec; 105(6):1361-6. PubMed ID: 18980214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orchestrating brain-cell renewal: the role of immune cells in adult neurogenesis in health and disease.
    Ziv Y; Schwartz M
    Trends Mol Med; 2008 Nov; 14(11):471-8. PubMed ID: 18929506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc in the physiology and pathology of the CNS.
    Sensi SL; Paoletti P; Bush AI; Sekler I
    Nat Rev Neurosci; 2009 Nov; 10(11):780-91. PubMed ID: 19826435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testosterone replacement therapy for the treatment of neurological and neuropsychiatric disorders.
    Gold SM; Voskuhl RR
    Curr Opin Investig Drugs; 2006 Jul; 7(7):625-30. PubMed ID: 16869115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal models of CNS disorders.
    McGonigle P
    Biochem Pharmacol; 2014 Jan; 87(1):140-9. PubMed ID: 23811310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The life, death, and replacement of oligodendrocytes in the adult CNS.
    McTigue DM; Tripathi RB
    J Neurochem; 2008 Oct; 107(1):1-19. PubMed ID: 18643793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In this issue of Recent Patents on CNS Drug Discovery, focus is laid upon the potential development of new therapeutic drugs for neurological and affective disorders through targeting the endocannabinoid system. Introduction.
    Recent Pat CNS Drug Discov; 2012 Apr; 7(1):1-2. PubMed ID: 22384488
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of pharmacogenetics in treating central nervous system disorders.
    Patnaik M; Renda MJ; Athanasiou MC; Reed CR
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1504-9. PubMed ID: 18849543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of insulin on the diseases of central nervous system].
    Yao XH; Shen K; Li XJ
    Sheng Li Ke Xue Jin Zhan; 2003 Jan; 34(1):21-6. PubMed ID: 12778804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biological restoration of central nervous system architecture and function: part 2-emergence of the realization of adult neurogenesis.
    Farin A; Liu CY; Langmoen IA; Apuzzo ML
    Neurosurgery; 2009 Apr; 64(4):581-60; discussion 600-1. PubMed ID: 19349822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The biological restoration of central nervous system architecture and function: part 1-foundations and historical landmarks in contemporary stem cell biology.
    Farin A; Liu CY; Elder JB; Langmoen IA; Apuzzo ML
    Neurosurgery; 2009 Jan; 64(1):15-39; discussion 34. PubMed ID: 19145154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translational CNS medicines research.
    Palmer AM; Alavijeh MS
    Drug Discov Today; 2012 Oct; 17(19-20):1068-78. PubMed ID: 22580061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of carbon nanotubes in neurology: clinical perspectives and toxicological risks.
    Nunes A; Al-Jamal K; Nakajima T; Hariz M; Kostarelos K
    Arch Toxicol; 2012 Jul; 86(7):1009-20. PubMed ID: 22547313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.